Brief: BioInvent: New Data From BI-1206 Triplet Combination In Lymphoma
11/06/2026 08:11
BRIEF-BioInvent: New Data From BI-1206 Triplet Combination In Lymphoma June 11 (Reuters) - BioInvent International AB BINV.ST:
BI-1206 TRIPLET ACHIEVES 83% ORR IN NON-HODGKIN'S LYMPHOMA POPULATION
BI-1206 TRIPLET SHOWS 14% SERIOUS ADVERSE EVENTS RATE, LOWER THAN COMPARATORS
Source text: ID:nMFN2sGzQz
Further company coverage: BINV.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))